Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Onco-Innovations Ltd. ( (TSE:ONCO) ).
Onco-Innovations Limited has partnered with Dalton Pharma Services to manufacture its proprietary nanoparticle formulation, PEO-b-PBz-CL, for preclinical animal studies. This initiative aims to optimize and scale up production to support regulatory filings and transition to Good Manufacturing Practice (GMP) manufacturing, enhancing Onco-Innovations’ pathway towards clinical readiness and strengthening its position in the oncology sector.
More about Onco-Innovations Ltd.
Onco-Innovations Limited is a Canadian-based company focused on cancer research and treatment, specializing in oncology. The company is dedicated to the prevention and treatment of cancer through pioneering research and innovative solutions, holding an exclusive worldwide license to patented technology targeting solid tumors.
Average Trading Volume: 83,872
Technical Sentiment Signal: Hold
For an in-depth examination of ONCO stock, go to TipRanks’ Overview page.